DAWN Stock Ownership Activity

DAY ONE BIOPHARMACEUTICALS I 13F holders

No value investing guru has made any change to the DAY ONE BIOPHARMACEUTICALS I (DAWN) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying DAWN now?

According to the latest SEC filing(s) DAY ONE BIOPHARMACEUTICALS I (DAWN) has not been purchased by any super investor.

To see more about who is investing in DAY ONE BIOPHARMACEUTICALS I (DAWN), please go to the DAWN ownership page.

2023 Q2 (1 result)
Ole Andreas Halvorsen
+64.16%
+1,000,000
+0.05%
0.13%
Current price: $12.79 7.12% Reported price*: $11.94
2022 Q3 (1 result)
Ole Andreas Halvorsen
-16.09%
-298,861
-0.03%
0.14%
Current price: $12.79 36.15% Reported price*: $20.03
2022 Q2 (1 result)
Ole Andreas Halvorsen
+60.48%
+665,000
+0.06%
0.14%
Current price: $12.79 28.55% Reported price*: $17.90
2021 Q4 (1 result)
Ole Andreas Halvorsen
-4.46%
-27,255
-0.00%
0.03%
Current price: $12.79 24.10% Reported price*: $16.85
2021 Q3 (1 result)
Ole Andreas Halvorsen
-9.69%
-130,000
-0.01%
0.08%
Current price: $12.79 46.10% Reported price*: $23.73
2021 Q2 (1 result)
Ole Andreas Halvorsen
buy
+1,260,912
+0.09%
0.09%
Current price: $12.79 43.83% Reported price*: $22.77
6 of 6

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.